Tiger Woods is not worth the dilution for the shareholders...but let's see how Musclepharm will use his endorsement.
Tiger Woods seems to be most popular among Asians...so, it could be interesting to see what plans Musclepharm got in stock for that part of the World.
In America, Tiger Woods got some popularity...but Im sure many wouldn't buy anything he endorsed to be honest. He just doesn't seem like a very likeable person to me....
In Europe, fak Tiger...we don't need his crocodile tears..
News 
Market Data 
Discover 
